New Drug on PBS for Chronic Kidney Disease Patients
Epworth Nephrologist, Professor Ian Fraser welcomed the Hon. Greg Hunt, Minister for Health, to Epworth Richmond on Thursday 20 December 2018 for the Federal government announcement of the drug Tolvaptan (Brand name Jinarc) being put on the PBS.
A number of families affected by genetic kidney disease were present to welcome the announcement that would save them around $23,000 per year and help them live a healthier life.
Trial investigator Professor Fraser said that the drug’s effectiveness has been established during the last ten years in two key global studies with Epworth being the number one recruiting site in Australia in both studies.
“For young adults with this condition, this is a breakthrough. This is the first drug which has been proven to be of benefit in the inherited condition, Autosomal Dominant Polycystic Kidney Disease (APKD). APKD effects over one in a thousand people, and commonly leads to kidney failure and dialysis in the mid 50s,” Professor Fraser said.
You can read more about the announcement by Minister Hunt here.
Photo by DS Images.
We caught up with Dr Kent Kuswanto, Epworth obstetrician and gynaecologist to talk all things periods.
Recipes brought to you by the Epworth team. You can’t stop at one slice and you’ll never know it’s gluten free! Slice & serve warm.
It’s been a year since we’ve been following sisters Alex and Jane’s bubs - Charlotte and Lola. It’s been a year since they both gave birth to their daughters, one at Epworth Freemasons and the other at Epworth Geelong. Let’s find out how life has changed since then.
An ovarian cyst is a fluid filled sac or pouch which forms on the ovary. Ovarian cysts, in most cases are harmless and resolve on their own. If the cyst is cancerous, it requires medical intervention. Ovarian cysts are common in women of childbearing age.
With 1 in 10 infants now developing a food allergy, being conscious of what you are buying and how you prepare food is more important than ever.